JohKKanetsunaYIshikawaYAizawaSNaitoISadoY. Diffuse mesangial sclerosis associated with Kawasaki disease: an analysis of alpha chains (alpha 1-alpha 6) of human type IV collagen in the renal basement membrane. Virchows Arch. 1997;430:489-494.
2.
LeeBWYapHKYipWCGiamYCTayJS. Nephrotic syndrome in Kawasaki disease. Aust Paediatr J. 1989;25:241-242.
3.
KrugPBoyerOBalzamoESidiDLehnertANiaudetP. Nephrotic syndrome in Kawasaki disease: a report of three cases. Pediatr Nephrol. 2012;27:1547-1550.
4.
RowleyAHShulmanSTMaskCA. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J Infect Dis. 2000;182:1183-1191.
5.
CaridiGTrivelliASanna-CherchiSPerfumoFGhiggeriGM. Familial forms of nephrotic syndrome. Pediatr Nephrol. 2010;25:241-252.
6.
VincentiFGhiggeriGM. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant. 2005;5:1179-1185.
7.
BertelliRTrivelliAMagnascoA. Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome. Clin Exp Immunol. 2010;161:151-158.
8.
ZhouLLHouFFWangGB. Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms. Kidney Int. 2009;76:1148-1160.
9.
BertelliRBodriaMNobileM. Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome. Clin Exp Immunol. 2011;166:55-63.
10.
LeeK-YRhimJ-WKangJ-H. Kawasaki disease: laboratory findings and an immunopathogenesis on the premise of a “protein homeostasis system”. Yonsei Med J. 2012;53:262-275.
